Table 4.
Management and outcome
| Number (N = 21) | Percentage (%) | |
|---|---|---|
| Antibiotherapy | ||
| Beta-lactam | ||
| Ceftriaxone (IV: 50 mg/kg/day) | 10 | 47.6 |
| Ampicillin (IV: 50 mg/kg/8 h) | 11 | 52.4 |
| Gentamicin (IV: 3 mg/kg/day) | 16 | 76.2 |
| Azithromycin (oral: 5-10 mg/kg/day) | 21 | 100 |
| Adjuvant therapy | ||
| Tramadol (IV: 1–2 mg/kg/6 h) | 9 | 42.9 |
| Paracetamol (oral or IV: 15 mg/kg/6 h) | 21 | 100 |
| Ibuprofen (oral: 10 mg/kg/8 h) | 5 | 23.8 |
| Hyperhydration (2.5–3 l/m2 BSa) | 21 | 100 |
| Anti-malarial treatment | ||
| No | 7 | 33.3 |
| Yes | 14 | 66.7 |
| Oxygen therapy | ||
| No | 14 | 66.7 |
| Yes | 7 | 33.3 |
| Transfusion | ||
| No | 7 | 33.3 |
| Yes | 14 | 66.7 |
| Death | ||
| Yes | 1 | 4.8 |
| No | 20 | 95.2 |
| Duration of hospitalization | ||
| ≤ 5 days | 8 | 38.1 |
| > 5 days | 13 | 61.9 |
aBS = Body surface; IV = intravenous